United States, EU, Japan, China, India and Southeast Asia Antisense and RNAi Therapeutics Market Size, Status and Forecast 2021

November 2016 | 112 pages | ID: U3AEEBA25A6EN
QYResearch

Abstracts

Notes:

Production, means the output of Antisense and RNAi Therapeutics

Revenue, means the sales value of Antisense and RNAi Therapeutics

This report studies the global Antisense and RNAi Therapeutics market, analyzes and researches the Antisense and RNAi Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Alnylam Pharmaceuticals
• Isis Pharmaceuticals
• Sanofi
• Glaxosmithkline
• Pfizer
• Allergan
• Antisense Therapeutics
• Ascletis
• AstraZeneca
• Novartis
• Atlantic Pharmaceuticals
• Benitec Biopharma
• Biogen Idec
• Takeda Pharmaceutical
• Bristol-Myers Squibb
• Teva Pharmaceutical
• Dainippon Sumitomo Pharma
• Dicerna Pharmaceuticals
• Enzon Pharmaceuticals
• F. Hoffmann-La Roche
• Gradalis

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Application, Antisense and RNAi Therapeutics can be split into

• Application 1
• Application 2
• Application 3

Contents

United States, EU, Japan, China, India and Southeast Asia Antisense and RNAi Therapeutics Market Size, Status and Forecast 2021

1 INDUSTRY OVERVIEW OF ANTISENSE AND RNAI THERAPEUTICS

1.1 Antisense and RNAi Therapeutics Market Overview
  1.1.1 Antisense and RNAi Therapeutics Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Antisense and RNAi Therapeutics Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Antisense and RNAi Therapeutics Market by End Users/Application
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application

2 GLOBAL ANTISENSE AND RNAI THERAPEUTICS COMPETITION ANALYSIS BY PLAYERS

2.1 Antisense and RNAi Therapeutics Market Size (Value) by Players (2015-2016)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Alnylam Pharmaceuticals
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.1.5 Recent Developments
3.2 Isis Pharmaceuticals
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.2.5 Recent Developments
3.3 Sanofi
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.3.5 Recent Developments
3.4 Glaxosmithkline
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.4.5 Recent Developments
3.5 Pfizer
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.5.5 Recent Developments
3.6 Allergan
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.6.5 Recent Developments
3.7 Antisense Therapeutics
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.7.5 Recent Developments
3.8 Ascletis
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.8.5 Recent Developments
3.9 AstraZeneca
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.9.5 Recent Developments
3.10 Novartis
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Antisense and RNAi Therapeutics Revenue (Value) (2011-2016)
  3.10.5 Recent Developments
3.11 Atlantic Pharmaceuticals
3.12 Benitec Biopharma
3.13 Biogen Idec
3.14 Takeda Pharmaceutical
3.15 Bristol-Myers Squibb
3.16 Teva Pharmaceutical
3.17 Dainippon Sumitomo Pharma
3.18 Dicerna Pharmaceuticals
3.19 Enzon Pharmaceuticals
3.20 F. Hoffmann-La Roche
3.21 Gradalis

4 GLOBAL ANTISENSE AND RNAI THERAPEUTICS MARKET SIZE BY APPLICATION (2011-2016)

4.1 Global Antisense and RNAi Therapeutics Market Size by Application (2011-2016)
4.2 Potential Application of Antisense and RNAi Therapeutics in Future
4.3 Top Consumer/End Users of Antisense and RNAi Therapeutics

5 UNITED STATES ANTISENSE AND RNAI THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Antisense and RNAi Therapeutics Market Size (2011-2016)
5.2 United States Antisense and RNAi Therapeutics Market Size and Market Share by Players (2015-2016)

6 EU ANTISENSE AND RNAI THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Antisense and RNAi Therapeutics Market Size (2011-2016)
6.2 EU Antisense and RNAi Therapeutics Market Size and Market Share by Players (2015-2016)

7 JAPAN ANTISENSE AND RNAI THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Antisense and RNAi Therapeutics Market Size (2011-2016)
7.2 Japan Antisense and RNAi Therapeutics Market Size and Market Share by Players (2015-2016)

8 CHINA ANTISENSE AND RNAI THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Antisense and RNAi Therapeutics Market Size (2011-2016)
8.2 China Antisense and RNAi Therapeutics Market Size and Market Share by Players (2015-2016)

9 INDIA ANTISENSE AND RNAI THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Antisense and RNAi Therapeutics Market Size (2011-2016)
9.2 India Antisense and RNAi Therapeutics Market Size and Market Share by Players (2015-2016)

10 SOUTHEAST ASIA ANTISENSE AND RNAI THERAPEUTICS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Antisense and RNAi Therapeutics Market Size (2011-2016)
10.2 Southeast Asia Antisense and RNAi Therapeutics Market Size and Market Share by Players (2015-2016)

11 MARKET FORECAST BY REGIONS AND APPLICATION (2016-2021)

11.1 Global Antisense and RNAi Therapeutics Market Size (Value) by Regions (2016-2021)
11.2 Global Antisense and RNAi Therapeutics Market Size (Value) by Application (2016-2021)
11.3 The Market Drivers in Future

12 ANTISENSE AND RNAI THERAPEUTICS MARKET DYNAMICS

12.1 Antisense and RNAi Therapeutics Market Opportunities
12.2 Antisense and RNAi Therapeutics Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Antisense and RNAi Therapeutics Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Antisense and RNAi Therapeutics Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antisense and RNAi Therapeutics Product Scope
Figure Global Antisense and RNAi Therapeutics Market Size (2011-2016)
Table Global Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Global Antisense and RNAi Therapeutics Market Share by Regions in 2015
Figure United States Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure EU Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure China Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure India Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Southeast Asia Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Figure Global Antisense and RNAi Therapeutics Market Share by Application in 2015
Figure Antisense and RNAi Therapeutics Market Size and Growth Rate in Applications 1 (2011-2016)
Figure Antisense and RNAi Therapeutics Market Size and Growth Rate in Applications 2 (2011-2016)
Figure Antisense and RNAi Therapeutics Market Size and Growth Rate in Applications 3 (2011-2016)
Table Antisense and RNAi Therapeutics Market Size (Value) by Players (2015-2016)
Figure Antisense and RNAi Therapeutics Market Size Share by Players in 2015
Figure Antisense and RNAi Therapeutics Market Size Share by Players in 2016
Table Alnylam Pharmaceuticals Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Alnylam Pharmaceuticals (2011-2016)
Figure Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Isis Pharmaceuticals Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Isis Pharmaceuticals (2011-2016)
Figure Isis Pharmaceuticals Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Sanofi Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Sanofi (2011-2016)
Figure Sanofi Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Glaxosmithkline Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Glaxosmithkline (2011-2016)
Figure Glaxosmithkline Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Pfizer Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Pfizer (2011-2016)
Figure Pfizer Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Allergan Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Allergan (2011-2016)
Figure Allergan Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Antisense Therapeutics Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Antisense Therapeutics (2011-2016)
Figure Antisense Therapeutics Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Ascletis Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Ascletis (2011-2016)
Figure Ascletis Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table AstraZeneca Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of AstraZeneca (2011-2016)
Figure AstraZeneca Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Novartis Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Novartis (2011-2016)
Figure Novartis Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Atlantic Pharmaceuticals Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Atlantic Pharmaceuticals (2011-2016)
Figure Atlantic Pharmaceuticals Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Benitec Biopharma Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Benitec Biopharma (2011-2016)
Figure Benitec Biopharma Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Biogen Idec Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Biogen Idec (2011-2016)
Figure Biogen Idec Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Takeda Pharmaceutical Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Takeda Pharmaceutical (2011-2016)
Figure Takeda Pharmaceutical Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Bristol-Myers Squibb Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Bristol-Myers Squibb (2011-2016)
Figure Bristol-Myers Squibb Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Teva Pharmaceutical Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Teva Pharmaceutical (2011-2016)
Figure Teva Pharmaceutical Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Dainippon Sumitomo Pharma Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Dainippon Sumitomo Pharma (2011-2016)
Figure Dainippon Sumitomo Pharma Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Dicerna Pharmaceuticals Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Dicerna Pharmaceuticals (2011-2016)
Figure Dicerna Pharmaceuticals Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Enzon Pharmaceuticals Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Enzon Pharmaceuticals (2011-2016)
Figure Enzon Pharmaceuticals Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table F. Hoffmann-La Roche Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of F. Hoffmann-La Roche (2011-2016)
Figure F. Hoffmann-La Roche Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Gradalis Basic Information List
Table Antisense and RNAi Therapeutics Business Revenue of Gradalis (2011-2016)
Figure Gradalis Antisense and RNAi Therapeutics Business Revenue Market Share in 2015
Table Global Antisense and RNAi Therapeutics Market Size by Application (2011-2016)
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2011
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2012
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2013
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2014
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2015
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2016
Table Top Consumer/End Users of Antisense and RNAi Therapeutics
Figure United States Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table United States Antisense and RNAi Therapeutics Market Size by Players (2011-2016)
Figure United States Antisense and RNAi Therapeutics Market Size Share by Players in 2015
Figure United States Antisense and RNAi Therapeutics Market Size Share by Players in 2016
Figure EU Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table EU Antisense and RNAi Therapeutics Market Size by Players (2011-2016)
Figure EU Antisense and RNAi Therapeutics Market Size Share by Players in 2015
Figure EU Antisense and RNAi Therapeutics Market Size Share by Players in 2016
Figure Japan Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table Japan Antisense and RNAi Therapeutics Market Size by Players (2011-2016)
Figure Japan Antisense and RNAi Therapeutics Market Size Share by Players in 2015
Figure Japan Antisense and RNAi Therapeutics Market Size Share by Players in 2016
Figure China Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table China Antisense and RNAi Therapeutics Market Size by Players (2011-2016)
Figure China Antisense and RNAi Therapeutics Market Size Share by Players in 2015
Figure China Antisense and RNAi Therapeutics Market Size Share by Players in 2016
Figure India Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table India Antisense and RNAi Therapeutics Market Size by Players (2011-2016)
Figure India Antisense and RNAi Therapeutics Market Size Share by Players in 2015
Figure India Antisense and RNAi Therapeutics Market Size Share by Players in 2016
Figure Southeast Asia Antisense and RNAi Therapeutics Market Size and Growth Rate by Regions (2011-2016)
Table Southeast Asia Antisense and RNAi Therapeutics Market Size by Players (2011-2016)
Figure Southeast Asia Antisense and RNAi Therapeutics Market Size Share by Players in 2015
Figure Southeast Asia Antisense and RNAi Therapeutics Market Size Share by Players in 2016
Figure Global Antisense and RNAi Therapeutics Market Size (Value) by Regions (2016-2021)
Table Global Antisense and RNAi Therapeutics Market Size by Regions (2016-2021)
Figure Global Antisense and RNAi Therapeutics Market Size Share by Regions in 2017
Figure Global Antisense and RNAi Therapeutics Market Size Share by Regions in 2021
Table Global Antisense and RNAi Therapeutics Market Size by Application (2016-2021)
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2017
Figure Global Antisense and RNAi Therapeutics Market Size by Application in 2021